Name: Decision Making in a World of Comparative Effectiveness Research: A Practical Guide (en Inglés)
Price: 172810.00 CLP
Availability: InStock
Author: Birnbaum, Howard G. ; Greenberg, Paul E.
ISBN: 9789811098284

portada Decision Making in a World of Comparative Effectiveness Research: A Practical Guide (en Inglés)

Formato

Libro Físico

Editorial

Adis

Autor

Birnbaum, Howard G. ; Greenberg, Paul E.

Idioma

Inglés

N° páginas

289

Encuadernación

Tapa Blanda

ISBN13

9789811098284

N° edición

Categorías

Economía
Investigación médica
Epidemiología y estadística médica
Farmacología

Decision Making in a World of Comparative Effectiveness Research: A Practical Guide (en Inglés)

Birnbaum, Howard G. ; Greenberg, Paul E. (Autor) · Adis · Tapa Blanda

Libro Nuevo

$ 172.810

$ 345.620

Ahorras: $ 172.810

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 04 de Junio y el Viernes 14 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Decision Making in a World of Comparative Effectiveness Research: A Practical Guide (en Inglés)"

In the past decade there has been a worldwide evolution in evidence-based medicine that focuses on real-world Comparative Effectiveness Research (CER) to compare the effects of one medical treatment versus another in real world settings. While most of this burgeoning literature has focused on research findings, data and methods, Howard Birnbaum and Paul Greenberg (both of Analysis Group) have edited a book that provides a practical guide to decision making using the results of analysis and interpretation of CER. Decision Making in a World of Comparative Effectiveness contains chapters by senior industry executives, key opinion leaders, accomplished researchers, and leading attorneys involved in resolving disputes in the life sciences industry. The book is aimed at 'users' and 'decision makers' involved in the life sciences industry rather than those doing the actual research. This book appeals to those who commission CER within the life sciences industry (pharmaceutical, biologic, and device manufacturers), government (both public and private payers), as well as decision makers of all levels, both in the US and globally.